Compounds > magnolol
Page last updated: 2024-08-25

magnolol and Lung Neoplasms

magnolol has been researched along with Lung Neoplasms in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Chen, K; Chen, L; Fu, S; Li, D; Liu, Z; Peng, A; Tang, H; Tang, M; Wan, L; Xue, L; Ye, H; Zhang, Y1
Chen, LJ; Deng, DX; Fu, SH; Liu, KJ; Liu, L; Luo, YZ; Ma, X; Pei, HY; Peng, AH; Tang, MH; Wang, L; Xue, LL; Yang, JH; Ye, HY; Zhao, M; Zhao, QY; Zheng, W; Zheng, YH1
Chen, JH; Chen, WL; Chueh, FS; Hsu, FT; Lee, YC; Wang, HY; Weng, YS; Wu, JY1
Hu, M; Li, G; Li, H; Liu, H; Ma, H; Shen, J; Yu, L; Zhang, T1
Hu, M; Li, F; Liu, W; Liu, Y; Liu, Z; Lu, L; Ou, R; Tong, Y; Wu, J; Yang, X; Zhang, G; Zheng, L1
Jeong, HJ; Kim, HM; Kim, MH; Seo, JU1
Hsieh, MT; Hsu, SL; Tsai, TH; Yang, SE1
Gao, JM; Guan, HQ; Li, HB; Li, JC; Yi, X; Ying, XX1

Other Studies

8 other study(ies) available for magnolol and Lung Neoplasms

ArticleYear
Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
    European journal of medicinal chemistry, 2018, Aug-05, Volume: 156

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Female; Human Umbilical Vein Endothelial Cells; Humans; Lignans; Lung Neoplasms; Magnolia; Mice, Inbred BALB C; Mice, Nude; Xenograft Model Antitumor Assays

2018
Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy.
    European journal of medicinal chemistry, 2021, Jan-01, Volume: 209

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Lignans; Lung Neoplasms; Magnolia; Mice, Inbred BALB C; Plant Extracts; Solubility; Structure-Activity Relationship

2021
Magnolol Induces Apoptosis Through Extrinsic/intrinsic Pathways and Attenuates NF-κB/STAT3 Signaling in Non-small-cell Lung Cancer Cells.
    Anticancer research, 2022, Volume: 42, Issue:8

    Topics: Apoptosis; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Lignans; Lung Neoplasms; NF-kappa B; STAT3 Transcription Factor

2022
Magnolol Inhibits the Growth of Non-Small Cell Lung Cancer via Inhibiting Microtubule Polymerization.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 42, Issue:5

    Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; G2 Phase Cell Cycle Checkpoints; Humans; Lignans; Lung Neoplasms; M Phase Cell Cycle Checkpoints; Magnolia; Male; Mice, Nude; Microtubules; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Transplantation, Heterologous; Tumor Suppressor Protein p53

2017
Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer.
    Pharmacological research, 2016, Volume: 111

    Topics: A549 Cells; Acetylation; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Proliferation; Dose-Response Relationship, Drug; Epigenesis, Genetic; Female; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Histones; Humans; Lignans; Lung Neoplasms; Magnolia; Mice, Inbred BALB C; Mice, Nude; Phytotherapy; Plant Extracts; Plants, Medicinal; Polyphenols; Promoter Regions, Genetic; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Tumor Burden; Xenograft Model Antitumor Assays

2016
Anticancer potential of magnolol for lung cancer treatment.
    Archives of pharmacal research, 2011, Volume: 34, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Culture Techniques; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Endothelial Cells; Endothelium, Vascular; Flow Cytometry; Humans; Lignans; Lung Neoplasms; Neovascularization, Pathologic; NF-kappa B; Poly(ADP-ribose) Polymerases

2011
Effector mechanism of magnolol-induced apoptosis in human lung squamous carcinoma CH27 cells.
    British journal of pharmacology, 2003, Volume: 138, Issue:1

    Topics: Apoptosis; Biphenyl Compounds; Carcinoma, Squamous Cell; Cell Line; Cell Survival; Gene Expression Regulation; Humans; Lignans; Lung Neoplasms; Magnolia; MAP Kinase Signaling System; Plant Bark; Plant Extracts; Tumor Cells, Cultured

2003
Magnolol-induced H460 cells death via autophagy but not apoptosis.
    Archives of pharmacal research, 2007, Volume: 30, Issue:12

    Topics: Antineoplastic Agents; Apoptosis; Autophagy; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; DNA; Humans; Lignans; Lung Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase

2007